CapitalStars Updates: INDIAN BENCHMARKS

CapitalStars Updates:

INDIAN BENCHMARKS are likely to start the session on a negative note as the global cues look unsupportive with SGX Nifty trading 42.00 points higher.

Headlines for the day: 

• Aurobindo Pharma receives USFDA approval for Raloxifene Hydrochloride
• Bharti Airtel & Idea Hike Post-paid Data Tariffs By 20% In Delhi
• ONGC, partners including OIL to invest $24 billion in Mozambique gas field        

Trend in FII flows: The FIIs were net  buyers of Rs   56.41 Cr in the cash segment on Friday while the DIIs were net  buyers of Rs   847.43 Cr, as per the provisional figures released by the NSE.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. CapitalStars also aveliable on social network

• CapitalStars Twitter
• CapitalStars Linkedin
• CapitalStars Facebook

CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX.

www.capitalstars.com | T:+91-731-6790000,6669900
CapitalStars Financial Research Financial Advisory Services